The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lyme Disease Support 1
Alumen, Calcarea carbonica, DNA, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali carbonicum, Kali muriaticum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, RNA, Silicea. · POTASSIUM ALUM 12 [hp_X]/59mL; OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/59mL; HERRING SPERM DNA 4 [hp_C]/59mL; FERROSOFERRIC PHOSPHATE 6 [hp_X]/59mL; CALCIUM SULFIDE 6 [hp_X]/59mL; POTASSIUM CARBONATE 6 [hp_X]/59mL; POTASSIUM CHLORIDE 6 [hp_X]/59mL; POTASSIUM SULFATE 6 [hp_X]/59mL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/59mL; SODIUM CHLORIDE 6 [hp_X]/59mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_X]/59mL; SACCHAROMYCES CEREVISIAE RNA 4 [hp_C]/59mL; SILICON DIOXIDE 12 [hp_X]/59mL · Liquid · Oral · Ohm Pharma Inc.
NDC 66096-0722-05 · 59 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Alumen, Calcarea carbonica, DNA, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali carbonicum, Kali muriaticum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, RNA, Silicea. (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ohm Pharma Inc. | POTASSIUM ALUM 12 [hp_X]/59mL; OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/59mL; HERRING SPERM DNA 4 [hp_C]/59mL; FERROSOFERRIC PHOSPHATE 6 [hp_X]/59mL; CALCIUM SULFIDE 6 [hp_X]/59mL; POTASSIUM CARBONATE 6 [hp_X]/59mL; POTASSIUM CHLORIDE 6 [hp_X]/59mL; POTASSIUM SULFATE 6 [hp_X]/59mL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/59mL; SODIUM CHLORIDE 6 [hp_X]/59mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_X]/59mL; SACCHAROMYCES CEREVISIAE RNA 4 [hp_C]/59mL; SILICON DIOXIDE 12 [hp_X]/59mL | Aug 26, 2026 | Sep 2, 2026 |
| Ohm Pharma Inc. | POTASSIUM ALUM 6 [hp_X]/59mL; OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/59mL; HERRING SPERM DNA 4 [hp_C]/59mL; FERROSOFERRIC PHOSPHATE 6 [hp_X]/59mL; CALCIUM SULFIDE 6 [hp_X]/59mL; POTASSIUM CARBONATE 12 [hp_X]/59mL; POTASSIUM CHLORIDE 6 [hp_X]/59mL; POTASSIUM SULFATE 6 [hp_X]/59mL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/59mL; SODIUM CHLORIDE 4 [hp_C]/59mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 12 [hp_X]/59mL; SACCHAROMYCES CEREVISIAE RNA 6 [hp_X]/59mL; SILICON DIOXIDE 6 [hp_X]/59mL | Jul 22, 2026 | Aug 19, 2026 |
| Ohm Pharma Inc. | CALCIUM SULFIDE 6 [hp_X]/59mL; FERROSOFERRIC PHOSPHATE 6 [hp_X]/59mL; HERRING SPERM DNA 4 [hp_C]/59mL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 6 [hp_X]/59mL; OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/59mL; POTASSIUM ALUM 12 [hp_X]/59mL; POTASSIUM CARBONATE 6 [hp_X]/59mL; POTASSIUM CHLORIDE 6 [hp_X]/59mL; POTASSIUM SULFATE 6 [hp_X]/59mL; SACCHAROMYCES CEREVISIAE RNA 4 [hp_C]/59mL; SILICON DIOXIDE 12 [hp_X]/59mL; SODIUM CHLORIDE 6 [hp_X]/59mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_X]/59mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lyme Disease Support 1 — NDC 66096-0722-05," retrieved September 3, 2026, https://drugdashboards.com/drug/66096072205.
Free to cite with attribution — see how the data is put together.